Search results
Results From The WOW.Com Content Network
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [3] [4] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. [5]
A week ago, Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) came out with a strong set of full-year numbers that could...
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund ...
The nature of investing is that you win some, and you lose some. And there's no doubt that Aerie Pharmaceuticals, Inc...
Pages in category "Pharmaceutical companies of China" The following 37 pages are in this category, out of 37 total. This list may not reflect recent changes .
Aerie Pharmaceuticals (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Guizhentang Pharmaceutical company ( Chinese: 福建归真堂药业股份有限公司 ), known by the short name of Guizhentang ( Chinese: 归真堂) is a company that profits from extracting bile out of Bile bears to make traditional Chinese medicine. The company is based in Fujian province of the People's Republic of China .